Robuta

Sponsor of the Day: Jerkmate
https://www.foxnews.com/health/breakthrough-als-study-launches-drug-aims-slow-disease-progression ALS drug pridopidine enters phase 3 trial as first participant enrolls | Fox News Apr 3, 2026 - An ALS drug trial testing pridopidine has entered phase 3 of the one-of-a-kind PREVAiLS study, aiming to slow disease progression in early-stage patients. phase 3 trialfox newsalsdrugenters https://www.biopharmadive.com/news/survodutide-obesity-drug-results-boehringer-ingelheim-zealand/818664/ Boehringer dual-acting obesity shot hits mark in Phase 3 trial | BioPharma Dive Survodutide spurred weight loss Wall Street analysts referred to as “Wegovy-like,” and showed signs it might help preserve muscle mass as well. phase 3 trialshot hitsbiopharma diveboehringerdual https://thedermdigest.com/acne-pipeline-update-sagimet-to-start-phase-3-trial-of-denifanstat-in-the-us/ Acne Pipeline Update: Sagimet to Start Phase 3 Trial of Denifanstat in the US - The Dermatology... Apr 27, 2026 - Sagimet Biosciences Inc. is planning to start a Phase 3 clinical trial of denifanstat in acne in the US during the second half of 2026. phase 3 trialacnepipelineupdatesagimet https://pharma-industry-review.com/lillys-jaypirca-outperforms-imbruvica-in-cll-head-to-head-phase-3-trial Lilly's Jaypirca Outperforms Imbruvica in CLL Head-to-Head Phase 3 Trial Jul 29, 2025 - BRUIN CLL-314 is the first ever head-to-head trial versus ibrutinib in CLL to include treatment-naïve patients. phase 3 triallillyoutperformscllhead